
Pfizer raises 2026 forecast on strong demand for blood thinner Eliquis
来源:Reuters发布于 2026-11-03
Pfizer raised its annual forecasts on Tuesday as strong demand for its cancer drugs and blockbuster blood thinner Eliquis helped the drugmaker post better-than-expected third-quarter results.
相关标的:PFE
本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。